SeoulMarkets · tag
governance
8 stories tagged “governance”, each from official Korean data with its source and timestamp.
A 75-point stake vanished — and the filing didn't name who took over
Tongyang Life's Chinese owner reported selling its entire stake in one filing, the largest exit in our ledger of Korean ownership disclosures. Of the nine biggest full sell-outs we found, only three say a controlling shareholder changed.
KG Mobility's convertible bond dilutes shares 22%
Five Korean convertible bonds filed this week all pay 0% surface interest — the option to convert is the entire return. Potential dilution on conversion ranges from 1.0% to 22.0%, and it isn't the biggest raise that dilutes least.
Celltrion's biggest buyback won't cancel a share
Celltrion's ₩100.0bn buyback dwarfs eight others filed with Korea's regulator this week — and carries no cancellation clause. The three firms that do promise to cancel are the smallest on the list.
Samsung Biologics raised 300x more, diluted 11x less
Samsung Biologics' ₩3.00tn rights issue diluted shareholders 4.7%. PhionX raised 300 times less — and diluted 53.8%, eleven times more. Twenty-one filings this week show size doesn't predict dilution.
Five Korean firms filed share buybacks today. Only one is cancelling the shares.
Buyback plans worth up to about 18 billion won reached the regulator on a single day. But the step that actually shrinks the share count — cancellation — appears in just one of them, Fims. The rest keep the stock in the drawer. Not advice.
At most Korean listed companies the boss has outlasted the workforce — often several times over
In seven of ten listed firms the chief executive has served longer than the average employee has worked there. The median CEO's tenure is 2.1 times the staff's, and a third run to three times or more. Not advice.
Korea's listed CEOs: the median has run the company eleven years, and hundreds far longer
Across filings for 2,455 listed companies, the median chief executive has served 11 years; 696 have led two decades or more, 77 over forty. We flag and exclude 148 whose reported tenure predates the company itself. Not advice.
Women hold about 7% of Korean listed-company board seats, and more than half of firms have none
Across 35,004 officers at Korea's listed companies, 7.2% are women. It splits by sector — 10.5% in health care, 4.2% in tech — and 56% of companies disclose no woman officer at all.